Women with schizophrenia to get new treatment option

Women with schizophrenia to get new treatment option

(Medical Xpress)—In a world first study, exciting new research has revealed that oestrogen can help treat schizophrenia in previously treatment-resistant women.

Led by Monash Alfred Psychiatry Research Centre (MAPrc) Professor Jayashri Kulkarni, the study is the first large-scale randomised-controlled trial in with treatment-resistant schizophrenia.

Conducted over several years, the research was deemed necessary after it was discovered that a specific focus for women with schizophrenia was lacking, with an urgent need for new treatment approaches.

The study, the largest clinical trial in the world of its type, found that in an eight week, three arm, double blind, placebo-controlled, adjunctive trial of estradiol, women who were given estradiol made better recoveries than those who were given a placebo.

Professor Kulkarni said persistent schizophrenia was common despite advances over the years in antipsychotic drug development, with little of the research focused on women.

"A specific focus for women with schizophrenia is still somewhat lacking and there is a real need to consider the special issues facing women with schizophrenia," Professor Kulkarni said.

"Since we are the pioneers in this area, with the optimal safe dose and delivery of estradiol being explored by our group in earlier , we felt this newer trial was necessary in the effective treatment of women with schizophrenia.

"What we found was that adjunctive estradiol treatment has practical use for women who have not responded well to antipsychotic drug treatment previously.

"We also found that due to the fluctuations of estrogen in women and its impact on mental state the premenstrual period, post natal and menopause phases of a woman's life are critical times for mental state changes. A team approach to her treatment is vital to the best health and mental health care outcomes."

Professor Kulkarni said she was excited about the positive results of the study, with trials of selective estrogen receptor modulators representing a hopeful future direction for schizophrenia research.

"There are many promising newer forms of hormone that offer great hope in the much-needed area of new, effective treatments for people with persistent and should be expanded to include men and postmenopausal women."

add to favorites email to friend print save as pdf

Related Stories

Gender separation in psychiatry

Jun 03, 2013

(Medical Xpress)—Results in a study of Australia's first women-only psychiatry ward at The Alfred have been published in the prestigious Journal of Clinical Psychiatry.

Recommended for you

Finding psychological insights through social media

Feb 28, 2015

Social media has opened up a new digital world for psychology research. Four researchers will be discussing new methods of language analysis, and how social media can be leveraged to study personality, mental and physical ...

Aggressive boys tend to develop into physically stronger teens

Feb 27, 2015

Boys who show aggressive tendencies develop greater physical strength as teenagers than boys who are not aggressive, according to new research published in Psychological Science, a journal of the Association for Psychological Scienc ...

New app helps monitor depression

Feb 27, 2015

Scientists from the University of Birmingham have developed an app that can measure the activity patterns of patients with depression and provide the necessary support.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.